Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
Clinical trial NCT00654589 · COMPLETED
Trial details
- NCT number
- NCT00654589
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2012-01-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.